Annenberg Oncology
Sameer Parikh, MBBS
Mutations, Sequencing, Resistance: Advances and Updates in Chronic Lymphocytic Leukemia
CME: 1 AMA ATT
Expires February 28, 2025
Go
John Anderson, MD • James Backes, PharmD • Deepak Bhatt, MD, MPH • Seth Martin, MD • Colleen Walsh-Irwin, DNP
Understanding Cholesterol Guidelines and Implementing Non-statins in High-Risk Populations: Paired Conversations and Case Vignettes
CME: 1.5 ACPE AMA ANCC ATT CABRN
Expires December 29, 2024
Go
Jeremy Abramson, MD, MMSc
Current and Emerging Therapies for Follicular Lymphoma: Solving Practice Challenges in Community-Based Interprofessional Care Teams
CME: 1 AAPA ACPE AMA ANCC ATT CABRN PHARM
Expires December 22, 2024
Go
Jason Luke, MD, FACP
Treatment Considerations in Cutaneous Melanoma: From Early Stage to Late/Advanced Stage
CME: 0.5 AMA ATT
Expires October 25, 2024
Go
Lipika Goyal, MD, MPhil
Advanced Cholangiocarcinoma: A New Era of Mechanisms and Management
CME: 0.5 AMA ATT
Expires October 25, 2024
Go
Brian Jonas, MD, PhD
Applying Evolving Targeted Therapy in Acute Myeloid Leukemia
CME: 0.75 ACPE AMA ANCC ATT CABRN PHARM
Expires September 30, 2024
Go
Sagar Lonial, MD, FACP
A Critical Update on Therapy Selection, Sequencing, and Toxicity Management of Novel Therapies for Multiple Myeloma
CME: 1 AMA ANCC ATT PHARM
Expires May 25, 2024
Go